Overview
Partial deletion of chromosome 3 syndrome (also referred to as partial monosomy 3 or 3p deletion syndrome / 3q deletion syndrome, depending on the specific chromosomal region involved) encompasses a group of rare chromosomal disorders caused by the loss of a segment of chromosome 3. Because chromosome 3 is a large chromosome containing many genes, the clinical presentation varies considerably depending on the size and location of the deleted segment (short arm 3p or long arm 3q). Common features across many cases include intellectual disability, developmental delay, growth retardation, and distinctive craniofacial dysmorphisms such as microcephaly, ptosis, broad nasal bridge, and micrognathia. Affected individuals may also present with congenital heart defects, skeletal anomalies, and genitourinary malformations. The severity of the condition depends largely on which genes are lost in the deletion. For example, deletions involving the distal short arm (3p25-pter) are frequently associated with more pronounced intellectual disability, speech delay, and characteristic facial features, while deletions of other regions may produce overlapping but distinct phenotypic profiles. Multiple organ systems can be affected, including the central nervous system, cardiovascular system, musculoskeletal system, and urogenital tract. Hearing loss and visual abnormalities have also been reported in some patients. There is no cure for partial deletion of chromosome 3 syndrome, and management is supportive and symptom-based. Treatment typically involves early intervention programs including speech therapy, physical therapy, and occupational therapy to optimize developmental outcomes. Cardiac defects or other structural anomalies may require surgical correction. Regular follow-up with a multidisciplinary team of specialists — including geneticists, cardiologists, neurologists, and developmental pediatricians — is recommended to monitor and address the diverse clinical manifestations of this condition.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Partial deletion of chromosome 3 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Partial deletion of chromosome 3 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Partial deletion of chromosome 3 syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Partial deletion of chromosome 3 syndrome.
Community
No community posts yet. Be the first to share your experience with Partial deletion of chromosome 3 syndrome.
Start the conversation →Latest news about Partial deletion of chromosome 3 syndrome
No recent news articles for Partial deletion of chromosome 3 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Partial deletion of chromosome 3 syndrome
What is Partial deletion of chromosome 3 syndrome?
Partial deletion of chromosome 3 syndrome (also referred to as partial monosomy 3 or 3p deletion syndrome / 3q deletion syndrome, depending on the specific chromosomal region involved) encompasses a group of rare chromosomal disorders caused by the loss of a segment of chromosome 3. Because chromosome 3 is a large chromosome containing many genes, the clinical presentation varies considerably depending on the size and location of the deleted segment (short arm 3p or long arm 3q). Common features across many cases include intellectual disability, developmental delay, growth retardation, and dis
At what age does Partial deletion of chromosome 3 syndrome typically begin?
Typical onset of Partial deletion of chromosome 3 syndrome is neonatal. Age of onset can vary across affected individuals.